FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3088479218> ?p ?o ?g. }

• W3088479218 abstract "Abstract Morbilliviruses, such as measles virus (MeV) and canine distemper virus (CDV), are highly infectious members of the paramyxovirus family. MeV is responsible for major morbidity and mortality in non-vaccinated populations. ERDRP-0519, a pan-morbillivirus small molecule inhibitor for the treatment of measles, targets the morbillivirus RNA-dependent RNA-polymerase (RdRP) complex and displayed unparalleled oral efficacy against lethal infection of ferrets with CDV, an established surrogate model for human measles. Resistance profiling identified the L subunit of the RdRP, which harbors all enzymatic activity of the polymerase complex, as the molecular target of inhibition. Here, we examined binding characteristics, physical docking site, and the molecular mechanism of action of ERDRP-0519 through label-free biolayer interferometry, photoaffinity cross-linking, and in vitro RdRP assays using purified MeV RdRP complexes and synthetic templates. Results demonstrate that unlike all other mononegavirus small molecule inhibitors identified to date, ERDRP-0519 inhibits all phosphodiester bond formation in both de novo initiation of RNA synthesis at the promoter and RNA elongation by a committed polymerase complex. Photocrosslinking and resistance profiling-informed ligand docking revealed that this unprecedented mechanism of action of ERDRP-0519 is due to simultaneous engagement of the L protein polyribonucleotidyl transferase (PRNTase)-like domain and the flexible intrusion loop by the compound, pharmacologically locking the polymerase in pre-initiation conformation. This study informs selection of ERDRP-0519 as clinical candidate for measles therapy and identifies a previously unrecognized druggable site in mononegavirus L polymerase proteins that can silence all synthesis of viral RNA. Importance The mononegavirus order contains major established and recently emerged human pathogens. Despite the threat to human health, antiviral therapeutics directed against this order remain understudied. The mononegavirus polymerase complex represents a promising drug target due to its central importance for both virus replication and viral mitigation of the innate host antiviral response. In this study, we have mechanistically characterized a clinical candidate small-molecule MeV polymerase inhibitor. The compound blocked all phosphodiester bond formation activity, a unique mechanism of action unlike all other known mononegavirus polymerase inhibitors. Photocrosslinking-based target site mapping demonstrated that this class-defining prototype inhibitor stabilizes a pre-initiation conformation of the viral polymerase complex that sterically cannot accommodate template RNA. Function-equivalent druggable sites exist in all mononegavirus polymerases. In addition to its direct anti-MeV impact, the insight gained in this study can therefore serve as a blueprint for indication spectrum expansion through structure-informed scaffold engineering or targeted drug discovery." @default.
• W3088479218 created "2020-10-01" @default.
• W3088479218 creator A5031097897 @default.
• W3088479218 creator A5070703755 @default.
• W3088479218 creator A5081819965 @default.
• W3088479218 creator A5082055954 @default.
• W3088479218 creator A5082590873 @default.
• W3088479218 date "2020-09-24" @default.
• W3088479218 modified "2023-10-17" @default.
• W3088479218 title "Therapeutic Targeting of Measles Virus Polymerase with ERDRP-0519 Suppresses All RNA Synthesis Activity" @default.
• W3088479218 cites W1539101560 @default.
• W3088479218 cites W1542698852 @default.
• W3088479218 cites W1573279341 @default.
• W3088479218 cites W1927044284 @default.
• W3088479218 cites W1979567338 @default.
• W3088479218 cites W1982098698 @default.
• W3088479218 cites W1993772444 @default.
• W3088479218 cites W1994384746 @default.
• W3088479218 cites W2022789500 @default.
• W3088479218 cites W2025091176 @default.
• W3088479218 cites W2026169010 @default.
• W3088479218 cites W2058336948 @default.
• W3088479218 cites W2058796888 @default.
• W3088479218 cites W2065386306 @default.
• W3088479218 cites W2067663266 @default.
• W3088479218 cites W2073618053 @default.
• W3088479218 cites W2076322352 @default.
• W3088479218 cites W2085811591 @default.
• W3088479218 cites W2087003322 @default.
• W3088479218 cites W2089883681 @default.
• W3088479218 cites W2093517417 @default.
• W3088479218 cites W2093830513 @default.
• W3088479218 cites W2106870343 @default.
• W3088479218 cites W2109666873 @default.
• W3088479218 cites W2113827448 @default.
• W3088479218 cites W2122431358 @default.
• W3088479218 cites W2134527874 @default.
• W3088479218 cites W2147590527 @default.
• W3088479218 cites W2148029848 @default.
• W3088479218 cites W2149322829 @default.
• W3088479218 cites W2150557298 @default.
• W3088479218 cites W2159579637 @default.
• W3088479218 cites W2163605487 @default.
• W3088479218 cites W2166783177 @default.
• W3088479218 cites W2168263596 @default.
• W3088479218 cites W2168918490 @default.
• W3088479218 cites W2298630271 @default.
• W3088479218 cites W2316631733 @default.
• W3088479218 cites W2419254034 @default.
• W3088479218 cites W2493888710 @default.
• W3088479218 cites W2769096492 @default.
• W3088479218 cites W2786899877 @default.
• W3088479218 cites W2891166015 @default.
• W3088479218 cites W2900192806 @default.
• W3088479218 cites W2971906485 @default.
• W3088479218 cites W3000729957 @default.
• W3088479218 cites W3006718532 @default.
• W3088479218 cites W3014540477 @default.
• W3088479218 cites W3014783738 @default.
• W3088479218 cites W3041755800 @default.
• W3088479218 cites W3042434201 @default.
• W3088479218 cites W3042583977 @default.
• W3088479218 doi "https://doi.org/10.1101/2020.09.23.311043" @default.
• W3088479218 hasPublicationYear "2020" @default.
• W3088479218 type Work @default.
• W3088479218 sameAs 3088479218 @default.
• W3088479218 citedByCount "0" @default.
• W3088479218 crossrefType "posted-content" @default.
• W3088479218 hasAuthorship W3088479218A5031097897 @default.
• W3088479218 hasAuthorship W3088479218A5070703755 @default.
• W3088479218 hasAuthorship W3088479218A5081819965 @default.
• W3088479218 hasAuthorship W3088479218A5082055954 @default.
• W3088479218 hasAuthorship W3088479218A5082590873 @default.
• W3088479218 hasBestOaLocation W30884792181 @default.
• W3088479218 hasConcept C104317684 @default.
• W3088479218 hasConcept C159047783 @default.
• W3088479218 hasConcept C159110408 @default.
• W3088479218 hasConcept C181199279 @default.
• W3088479218 hasConcept C22070199 @default.
• W3088479218 hasConcept C2522874641 @default.
• W3088479218 hasConcept C2776438120 @default.
• W3088479218 hasConcept C2776449523 @default.
• W3088479218 hasConcept C2778199166 @default.
• W3088479218 hasConcept C2780355102 @default.
• W3088479218 hasConcept C2780727368 @default.
• W3088479218 hasConcept C2780813555 @default.
• W3088479218 hasConcept C41258723 @default.
• W3088479218 hasConcept C41685203 @default.
• W3088479218 hasConcept C54355233 @default.
• W3088479218 hasConcept C55493867 @default.
• W3088479218 hasConcept C67705224 @default.
• W3088479218 hasConcept C71924100 @default.
• W3088479218 hasConcept C82381507 @default.
• W3088479218 hasConcept C86803240 @default.
• W3088479218 hasConceptScore W3088479218C104317684 @default.
• W3088479218 hasConceptScore W3088479218C159047783 @default.
• W3088479218 hasConceptScore W3088479218C159110408 @default.
• W3088479218 hasConceptScore W3088479218C181199279 @default.
• W3088479218 hasConceptScore W3088479218C22070199 @default.
• W3088479218 hasConceptScore W3088479218C2522874641 @default.

• next